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Abstract
Thioacetamide (TA) is a model hepatotoxin that undergoes metabolic activation via two 
successive S-oxidations. The ultimate toxic metabolite thioacetamide S,S-dioxide, or its tautomer 
acetimidoyl sulfinic acid CH3C(NH)SO2H, then acylates lysine side chains on cellular proteins 
leading to cellular dysfunction or death. To identify individual target proteins, quantitate the extent 
of their modification and elucidate the structural details of their modification we required both 
radio-labeled and stable-labeled forms of TA and its intermediate metabolite thioacetamide S-
oxide (TASO). The latter is stable when purified but can be difficult to isolate. Considering 
currently available isotopic precursors we devised and report here methods for the synthesis and 
isolation of TA and TASO labeled with C-14, C-13 and/or deuterium. The methods are 
straightforward, utilize readily available precursors and are amenable to small scale.
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Introduction
Thioacetamide (TA, 1), a prototype thiono-sulfur (>C=S) compound, has been used 
industrially in the leather, textile, and paper industries, as an accelerator in the vulcanization 
of buna rubber, as a stabilizer in motor fuels and as a replacement for hydrogen sulfide in 
qualitative analysis.1 TA was also once used as a fungicide on oranges but it was reported 
that a single dose of this toxin in animals can produce centrilobular necrosis, and that 
chronic administration leads to liver cirrhosis and even hepatocarcinoma.2 More recently 
thioacetamide has been used to generate useful animal models of hepatic fibrosis, 3 hepatic 
cirrhosis4 and human cholangiocarcinoma.5 Thioacetamide6, 7 and its congener 
thiobenzamide (TB, PhCSNH2)8, 9 are also widely used to model acute hepatotoxicity. The 
cytotoxicity of both thioamides is believed to result from a two-step bioactivation sequence 
leading first to a thioamide S-oxide such as TASO (2) and then to a reactive S,S-dioxide 
such as TASO2 (3) (Scheme 1).10, 11 The iminosulfinic acid tautomers of TASO2 and 
TBSO2 are highly reactive acylating agents toward lysine residues in proteins and may 
initiate necrosis by covalently binding to liver macromolecules.8, 12
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Whereas numerous specific cellular protein targets have been identified for thiobenzamide,8 
and a number of other metabolically activated pro-toxins,13 no specific cellular targets for 
TA metabolites have thus far been identified. Detection of proteins adducted by reactive 
metabolites commonly depends on treating animals or cells with isotopically labeled 
protoxins, followed by 2D gel electrophoresis and identification of targets by mass 
spectrometric analysis. Herein, we report simple and efficient methods for the synthesis of 
TA and TASO from sodium acetate labeled with either 14C or 13C and deuterium.
Experimental
[1–14C]-Acetic acid, sodium salt (59.6 mCi/mmol and radiochemical purity >98 %) was 
obtained from Moravek Biochemical (California, USA). [1,2-13C]-acetic acid-d3, sodium 
salt was obtained from Cambridge Isotopes (Massachusetts, USA). All other chemicals and 
solvents were obtained from Sigma Aldrich. Hydrogen peroxide was titrated iodometrically 
before use. 1H and 13C NMR spectra were recorded on Bruker AV III 500 MHz 
spectrometer and spectra were referenced to the residual NMR solvent peak. Electrospray 
ionization spectra were acquired on a LCT Premier time of flight mass spectrometer. 
GC/MS analyses were conducted with an Agilent 6890N GC interfaced with a quadrupole 
mass analyzer using an injector temperature of 240 °C and an initial column temperature of 
50 °C for 1 min followed by a gradient of 50–300 °C over 13 min. Ionization was by 
electron impact at 70eV. Thin-layer chromatography was performed on Silica Gel GF plates 
(2.5 × 10 cm, 0.25 mm) with fluorescence detection under UV light at 254 nm for TA and 
TASO, or by spraying the plate with 0.05% Rhodamine 6G in 95% ethanol to detect 
acetamide under UV or ambient light. After eluting with 10% methanol in ethyl acetate 
(v/v), the Rf values for TA, acetamide and TASO were 0.80, 0.55 and 0.35, respectively. 
Column chromatography was performed using silica gel (63–200 particle size). 
Radioactivity was measured using a Packard Tri-Carb liquid scintillation counter.
Thioacetamide S-oxide (TASO, 2)
Thioacetamide, 1 (0.050 g, 0.666 mmol) was dissolved in 1 mL methanol in a 50 mL screw-
capped Corex tube. The solution was cooled to 0 °C and hydrogen peroxide (30% w/w, 10.9 
M by iodometric titration, 0.046 mL, 0.501 mmol) was added. After stirring for 2 h at 0 °C, 
the solvent was removed (rotovap, bath temperature ≤37 °C). The residue was dissolved in a 
small quantity of methanol and transferred to a column packed with 20 g silica gel in ethyl 
acetate. Elution was started with MeOH/ethyl acetate (v/v = 1:9) and compound 2 was 
eluted with MeOH/ethyl acetate (v/v = 1:4). Removal of the solvent provided 2 as a 
crystalline white solid (0.054 g, 0.593 mmol, 89% yield). 1H NMR (DMSO-d6): δ 1.94 (s, 
3H), 8.19 (s, 1H), 9.01 (s, 1H). 13C NMR: δ 13.83 (−CH3), 189.97 (>C=S). TOF MS calcd 
for C2H5OSN [M + H]+ 92.0170, found 92.0159. The purified material was quite stable for 
several months when stored as a crystalline solid in a freezer (ca. −20 °C), as judged by TLC 
and by retention of its well defined colorless crystalline appearance as tiny plates and 
pincushions.
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[1–14C]-Acetic acid, sodium salt (4, 0.017 g, 0.126 mmol, 7.5 mCi) was dissolved in 1 mL 
methanol and transferred to a 12 mL screw-capped culture tube and solid ammonium acetate 
(5, 0.087 g, 1.134 mmol) was added. After dissolution the homogeneous mixture was 
evaporated to dryness (rotovap). The tube was capped tightly and placed in a six inch length 
of galvanized iron pipe closed at both ends with threaded pipe caps. The bottom 1.5 inches 
of the upright assembly was immersed in a sand bath heated electrically to ca. 240 °C 
overnight (ca. 24 hr) (Scheme 3). After cooling to room temperature the water formed 
during pyrolysis was removed using a rotovap yielding crude acetamide (6, 0.074 g, 1.254 
mmol, quantitative yield) as a highly viscous pale yellow liquid. Tetrahydrofuran (THF, 4 
mL) and Lawesson’s reagent (0.510 g, 1.254 mmol) were added directly to the crue product 
and the mixture was stirred at room temperature for 2 h. With no work-up, the reaction 
mixture was transferred to a column packed with 20 g silica gel in ethyl acetate/hexane (1:9 
v/v); thioacetamide (7) was eluted using ethyl acetate/hexane (1:2 v/v). Removal of the 
solvent provided 7 as crystalline white solid (0.014 g, 0.187 mmol, specific activity 5.65 
mCi/mmol). Radiochemical purity as assessed by TLC was ca. 98%.
[1–14C]-Thioacetamide S-oxide (8)
Compound 7, (0.004 g, 0.054 mmol, 5.65 mCi/mmol) was combined with ordinary 
thioacetamide (0.008 g, 0.110 mmol) in 2 mL methanol in a culture tube containing a 
magnetic stirring bar (Scheme 2). The reaction mixture was cooled to 0 °C, H2O2 (10.9 M 
by iodometric tiration, 0.012 mL, 0.130 mmol) was added and the reaction was stirred at 0 
°C for 2 h. After removal of solvent (rotovap, bath temperature ≤37 °C), the residue was re-
dissolved in a small volume of methanol and transferred to a column of silica gel (20 g) 
packed in ethyl acetate. Elution began with MeOH/ethyl acetate (1:9 v/v) and compound 8 
was eluted with MeOH/ethyl acetate (1:4 v/v). Removal of the solvent provided 8 as a 
crystalline white solid (0.012 g, 0.132 mmol, 1.90 mCi/mmol)
[1,2-13C]-Acetic acid-d4 (10)
A 50 mL pear-shaped flask (19/22 joint) was charged with 1.0 mL of D3PO4 (prepared by 
adding 2 vol of D2O to 85% H3PO4 and then removing excess water using a rotary 
evaporator at ca. 70 °C for a total of three cycles of D-exchange). The use of D3PO4 rather 
than H3PO4 was precautionary to prevent loss of deuterium by exchange. [1,2-13C]-acetic 
acid-d3, sodium salt trihydrate (9, 0.508 g, 3.603 mmol) was then added as a solid powder 
on top of the D3PO4, the flask was rotated several turns to mix and spread out the viscous 
mass on the walls. It was immediately affixed to a 135° bend connecting tube leading to a 
vacuum distillation adapter that terminated in a 50 mL round bottom receiving flask. After 
cooling the receiver flask to −78 °C (Dry Ice/acetone) the system was evacuated to ca. 1 torr 
and the distillation flask was heated gently with a hair dryer until the acetic acid that was 
generated all collected in the receiver as a frozen white solid. Compound 10 was thus 
obtained as colorless liquid at room temperature (0.258 g, 3.91 mmol). Identity, purity and 
complete retention of deuterium was confirmed by GC/MS analysis of a tiny aliquot 
dissolved in methanol to wash out the single easily exchangeable proton of the acid group.
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Compound 10 (0.240 g, 3.636 mmol) was cooled to −78 °C in a 50 mL round bottom 
receiver flask, anhydrous ammonia (2 M solution in ethanol, 2.2 mL, 4.4 mmol) was added, 
and the reaction mixture was allowed to warm to room temperature. Successive portions of 
the solution were transferred to a 16 × 100 mm screw-cap culture tube and the solvent was 
removed by rotary evaporation. Once all the material was pooled and evaporated, methanol-
O-d (1.5 mL) was added to the residue (11) and then removed by rotary evaporation to wash 
out all exchangeable hydrogens; this step was repeated one more time. Final evaporation of 
the solvent afforded 12 as colorless viscous liquid (0.200 g, 2.326 mmol). The tube was then 
capped and placed in a metal pipe and heated at 240 °C for 24 h as described for 7 above. 
After cooling, the water formed during pyrolysis was removed (rotovap) to give 13 as 
colorless viscous liquid (0.040 g, 0.625 mmol). Complete retention of deuterium was 
confirmed by GC/MS analysis of a tiny aliquot dissolved in methanol to wash out the two 
exchangeable protons of the amide group. Compound 13 (0.035 g, 0.547 mmol) was 
dissolved in 2 mL THF in a culture tube with a magnetic stirring bar. Lawesson’s reagent 
(0.221 g, 0.547 mmol) was added and the reaction mixture was stirred at room temperature 
for 2 h. Solvent was then removed (rotovap), the crude product was redissolved in small 
amount of ethyl acetate, and the solution was transferred to a column packed with 20 g silica 
gel in ethyl acetate/hexane (1:9 v/v). Compound 14 was eluted with ethyl acetate/hexane 
(1:2 v/v). Removal of the solvent provided 14 as crystalline white solid (0.012 g, 0.150 
mmol). GC-MS examination of a methanol solution of 14 showed the expected molecular 
ion at 80 (vs. 75 for unlabeled TA) and indicated complete retention of deuterium.
[1,2-13C, 2,2,2-2H3]-Thioacetamide S-oxide (15)
Compound 14 (0.010 g, 0.125 mmol) was dissolved in 1 mL methanol and oxidized with 
standardized hydrogen peroxide solution, and isolated by chromatography as described for 2 
above. Removal of solvent provided 15 as tiny white crystals (0.006 g, 0.062 mmol). TOF 
MS calcd for 13C2H2D3OSN [M + H]+ 97.0425, found 97.0439.
Results and Discussion
Thioacetamide S-oxide is a stable compound when pure, but its synthesis and isolation are 
complicated by its extreme polarity and high water solubility. It was first synthersized by 
Walter who treated TA with aqueous hydrogen peroxide saturatred with ammonium 
sulfate.14 Later Porter and Neal prepared TASO on a 40 g scale by oxidizing TA with 
hydrogen peroxide in DMF and isolating the product by precipitation with carbon 
disulfide.15 They also prepared [1–14C]-TASO by oxidizing [1–14C]-TA (obtained 
commercially) with excess hydrogen peroxide in acetone and isolating the product by low 
temperature crystallization.
As a precursor for the synthesis of isotopically labeled TASO, labeled TA has been prepared 
by addition of H2S to acetonitrile and by thionation of acetamide (Scheme 2). Anthoni et 
al.16 prepared 2H-, 13C-, and 15N-variants of acetonitrile by reacting CH3I with KCN in 
glycerol (94–98% yield) and converting the latter to TA using Ph2PS2H in toluene (55% 
yield after sublimation). Porter et al.11 synthesized [3H]-TA by treating [3H]-MeCN with 
Sarma and Hanzlik Page 4













(EtO)2PS2H in 40–70% overall yield. Benincori et al.17 prepared [13C2]-TA at 5% 
enrichment in 30% overall yield by refluxing an mixture of [13C2]-acetic acid with urea and 
thionating the resulting acetamide product using P2S5 and K2S in toluene.
For the identification of hepatocyte proteins adducted by TA metabolites we first needed 
[14C]-TA to quantitate the overall extent of protein adduction and to locate adducted protein 
spots on 2D gels by phosphorimaging. To facilitate the mass spectral analysis of tryptic 
peptides derived from the radioactive spots, we also wanted a stable isotope signature 
having a mass shift of at least 5 AMU8, 18 in the TA and its metabolites. Considering the 
potential isotopic precursors currently available commercially, we chose to begin with 
sodium [1–14C]-acetate and sodium [1,2-13C2-2,2,2-2H3]-acetate (Schemes 3 and 4, 
respectively).
Our syntheses of [14C]-TA was predicated on an early report by Hofmann19 indicating that 
acetamide could be prepared simply by pyrolyzing ammonium acetate. We therefore 
combined sodium [1–14C]-acetate at high specific activity with an excess of ammonium 
acetate in methanol (to ensure isotopic mixing and to achieve the desired final specific 
activity), evaporated the solvent, and pyrolyzed the resulting material overnight in a sealed 
screw-cap culture tube (protected inside a metal pipe). The acetamide product, formed in 
essentially quantitative yield, was thionated with Lawesson's reagent in THF to give [14C]-
thioacetamide, and the latter was oxidized to [14C]-TASO in ca. 30% overall yield. We 
discovered that it was quite critical to control the amount of H2O2 added to just under 1.0 
mol-equivalent in order to prevent overoxidation of the TA, and to avoid having un-oxidized 
TA as an impurity in the material intended for metabolic studies. When stored as a 
crystalline solid at −20 °C, TASO was found to be stable for several months.
We expected the synthesis of [1,2-13C2-2,2,2-2H3]-TA to proceed almost as easily, but were 
surprised by the ease with which the deuterium atoms could be lost during the pyrolysis 
step, apparently by exchange with the amide NH2 protons. Therefore a slightly more 
elaborate route was devised (Scheme 4). Sodium [1,2-13C2-2,2,2-2H3]-acetate (9) was 
converted to acetic acid-d4 using 85% phosphoric acid (i.e., H3PO4•H2O) that had been 
deuterated by several cycles of adding and evaporating D2O to give (D3PO4•D2O). This 
completely avoided the partial loss of deuterium that occurred when non-deuterated 85% 
H3PO4 was used. The labeled acetic acid (10) was isolated by bulb-to-bulb transfer under 
vacuum in essentialy quantitative yield and then neutralized with anhydrous ammonia in 
ethanol to give ammonium acetate 11 with full deuterium retention as verified by mass 
spectrometry. Since pyrolysis of this material consistently lead to the loss of most of the 
deuterium from the methyl group, we surmised that the protons of the ammonium group of 
salt 11 were the source of hydrogens. Prior exchange of these with methanol-O-d afforded 
labeled ammonium acetate 12, pyrolysis of which produced acetamide 13 with no loss of 
deuterium from the methyl group. The latter was then thionated with Lawesson's reagent and 
carefully oxidized to TASO using 1.0 eq. of hydrogen peroxide.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Metabolic activation of thioamides.
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Synthetic routes to isotopically-labeled thioacetamide and thioacetamide S-oxide.
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Synthesis of [1-14C]-thioacetamide S-oxide (a) pyrolysis in sealed screw-cap tube, 240 °C, 
24 h;(b) Lawesson’ reagent, THF, r.t. 2h; (c) 0.95 eq. H2O2, MeOH, 0 °C, 2h.
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Synthesis of stable labeled TASO
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